New York Oncology Hematology Executive, Edwin Graham, Tapped for Regional Leadership Role

June 18, 2014

ALBANY, NY – New York Oncology Hematology (NYOH), an affiliate of The US Oncology Network, today announced the appointment of Edwin Graham to the position of Northeast Regional Senior Vice President for The US Oncology Network. In his new role, Graham will continue to work with NYOH and other affiliates in The Network, helping practices better serve patients through partnerships, expansion of services and other growth initiatives. He will also pursue new opportunities for cancer practices across the Northeast to join one of the nation’s leading networks of cancer care providers. NYOH, which is united with 1,000 oncology physicians from across the country, is the Capitol Region’s leading provider of community-based, physician-owned cancer care services.

“Ed’s commitment to high performance and consistent leadership have helped NYOH continue its mission of reducing the incidence of cancer and blood diseases through earlier detection and intervention, and by offering patients the most appropriate, evidence-based treatment options,” said Michael V. Seiden, M.D., Ph.D., Chief Medical Officer for The US Oncology Network. “Ed’s depth and breadth of experience make him an excellent choice to manage the expansion of cancer practices across the Northeast, and lead our effort to continually offer the oncology community the most therapeutic benefit available.”

Graham, who has more than 30 years of experience as a health care executive, took the reins as Executive Director of NYOH in 2012, and during his tenure oversaw significant growth for the NY Capitol Region-based cancer care provider. Under his leadership, NYOH hired six new physicians with ongoing recruitment and invested more than $5 million in new technology. Most recently, Graham and his team announced construction of a brand new, 28,000 square foot Clifton Park Cancer Center, to open in 2015.

Prior to joining NYOH, Graham served as Vice President for the Community Health Care Association of New York State before joining NYOH. As the former CEO of Gilda’s Club of the Capital Region, he oversaw the successful merger with the American Cancer Society. Ed has also held executive leadership roles at the Foundation for Quality Care, Kaiser Permanente and the former Child’s Hospital. He was also appointed by Governor David Paterson to the New York State Hospital Review and Planning Council.

“I’m thrilled to take a position that allows me to continue to grow cancer care resources for patients while still emphasizing the importance of bringing evidence-based, high-quality care to patients close to home,” said Graham.

About New York Oncology Hematology

New York Oncology Hematology (NYOH) is the region’s leading provider of community-based cancer care and services. With seven convenient locations, a team of 36 physicians, and more than 300 oncology professionals, NYOH has been delivering world class cancer care to the Capital Region and surrounding communities for more than 30 years.

NYOH is united in healing with The US Oncology Network, one of the nation’s largest networks of integrated community-based oncology practices dedicated to advancing high-quality, evidence-based cancer care. As an affiliate of The US Oncology Network, NYOH is united with nearly 1,000 physicians nationwide.

NYOH participates in clinical trials through US Oncology Research, which has played a role in 48 FDA-approved cancer therapies, nearly one-third of all cancer therapies approved by the FDA to date. Currently, cancer patients in the Capital Region are participating in dozens of clinical drug trials through NYOH’s research operation, which provides them opportunities for improved care and helps to further medicine for patients in the future. For more information, visit

About The US Oncology Network

The US Oncology Network is one of the nation’s largest networks of integrated, community-based oncology practices dedicated to advancing high-quality, evidence-based cancer care. A physician-led organization, The US Oncology Network unites like-minded physicians and clinicians around a common vision of improving patient outcomes and quality of life. Leveraging healthcare information technology, shared best practices, evidence-based guidelines and quality measurements, physicians within The US Oncology Network are pioneering new ways to achieve this vision. The US Oncology Network is committed to strengthening patient access to integrated care in local communities across the nation, including collaboration with a variety of payers, hospitals and academic institutions. The US Oncology Network is supported by McKesson Specialty Health, a division of McKesson Corporation focused on empowering a vibrant and sustainable community patient care delivery system. For more information, visit

Public Relations Contact